Helsinn Group Announces Upcoming Presentation of Phase III data in NEPA (netupitant/palonestron) at MASCC/ISOO Congress in Washington DC
BioTech Gate,
Lugano, Switzerland, June 20, 2017 - Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products…